[Acute agranulocytosis. Clinical study of thirty-two cases (author's transl)].
Acute agranulocytosis is a serious accident if the nature of the accident and the responsible drug are ignored or if it happens to a weak patient. Among thirty two cases of hospitalization, probably chosen according to their seriousness, the authors recall the diversity of the symptoms, the risk of the abuse of the "pyrazol compound" (70% of agranulocytosis) and the frequency of relapse (30%). The prognosis depends on the risk of infection. Septicemy is rare (15%), often foreseeable depending on the state of the patient. Agranulocytosis remains serious in spite of a wide range antibiotics administered in the early stages.
D000208:Acute Disease; D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced / Q000175:diagnosis* / Q000276:immunology; D000700:Analgesics / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis; D001424:Bacterial Infections / Q000188:drug therapy; D001773:Blood Cells; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011720:Pyrazoles / Q000009:adverse effects; D012008:Recurrence
D000700:Analgesics; D000900:Anti-Bacterial Agents; D001323:Autoantibodies; D011720:Pyrazoles
Agranulocytoses aiguës. Etude clinique de trente-deux épisodes.